Disease, Disability, and Injury Prevention and Control Special Emphasis Panel “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 7),” Request for Application Number (RFA) DP07-002, 19522 [E7-7332]
Download as PDF
<![CDATA[
19522
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices
Dated: April 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–7331 Filed 4–13–07; 10:39 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel ‘‘Health Promotion
and Disease Prevention Research
Centers: Special Interest Project
Competitive Supplements (Panel 7),’’
Request for Application Number (RFA)
DP07–002
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 12 p.m.–4 p.m., June 5,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications
received in response to RFA DP07–002,
‘‘Health Promotion and Disease Prevention
Research Centers: Special Interest Project
Competitive Supplements (Panel 7).’’
Contact Person for More Information:
Sheree Marshall Williams, PhD, M.Sc.,
Scientific Review Administrator, Centers for
Disease Control and Prevention, 1600 Clifton
Road, NE., MS D72, Atlanta, GA 30333,
telephone 404.639.4896.
pwalker on PROD1PC71 with NOTICES
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: April 10, 2007.
Elaine L. Baker
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–7332 Filed 4–17–07; 8:45 am]
BILLING CODE 4163–18–P
VerDate Aug<31>2005
17:04 Apr 17, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control Initial Review Group
(NCIPC/IRG)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meetings of the
aforementioned committee:
Times and Dates:
2 p.m.–5 p.m., May 14, 2007 (Closed).
2 p.m.–5 p.m., May 15, 2007 (Closed).
2 p.m.–5 p.m., May 16, 2007 (Closed).
2 p.m.–5 p.m., May 17, 2007 (Closed).
2 p.m.–5 p.m., May 18, 2007 (Closed).
Place: The conference calls will
originate at the Centers for Disease
Control and Prevention, Vanderbilt
Building, Koger Center, Atlanta,
Georgia.
Times and Dates:
9 a.m.–10 a.m., May 21, 2007 (Open).
10 a.m.–5 p.m., May 21, 2007
(Closed).
9 a.m.–3 p.m., May 22, 2007 (Closed).
3 p.m.–5 p.m., May 22, 2007 (Open).
5 p.m.–7 p.m., May 22, 2007 (Closed).
9 a.m.–5:30 p.m., May 23, 2007
(Closed).
9 a.m.–5 p.m., May 24, 2007 (Closed).
Place: Sheraton Midtown Atlanta
Hotel Colony Square, Atlanta, Georgia.
Status: Portions of the meetings will
be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Section 10(d)
of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services, and the Director, CDC,
concerning the scientific and technical
merit of grant and cooperative
agreement applications received from
academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct
specific injury research that focuses on
prevention and control.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of individual research grant
and cooperative agreement applications
submitted in response to two Fiscal
Year 2007 Requests for Applications
related to the following individual
research announcements: 07002, Family
and Dyadic Focused Interventions to
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Prevent Intimate Partner Violence;
07003, Maximizing Protective Factors
for Youth Violence; 07004, Abusive
Head Trauma (AHT) Prevention; 07005,
Understanding Bullying and Sexual
Violence Perpetration and Factors
Associated with Both Outcomes; 07006,
Grants for Traumatic Injury
Biomechanics Research; 07007,
Dissemination Research on Fall
Prevention: ‘‘Stepping On’’ in a U.S.
Community Setting; and 07008, The
Impact of Traumatic Brain Injury
Among Incarcerated Persons.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Jane Suen, PhD, NCIPC/IRG, CDC, 4770
Buford Highway, NE., M/S K02, Atlanta,
Georgia 30341–3724, telephone 770/
488–1240.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: April 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–7339 Filed 4–17–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1080, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 72 FR 14578, dated
March 28, 2007) is amended to reflect
the reorganization of the Coordinating
Center for Infectious Diseases, Centers
for Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the mission
statements for the Coordinating Center
for Infectious Diseases (CV) and the
Office of the Director (CVA), and insert
the following:
E:\FR\FM\18APN1.SGM
18APN1
]]>Agencies
[Federal Register Volume 72, Number 74 (Wednesday, April 18, 2007)]
[Notices]
[Page 19522]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7332]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel ``Health Promotion and Disease Prevention Research
Centers: Special Interest Project Competitive Supplements (Panel 7),''
Request for Application Number (RFA) DP07-002
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting of the aforementioned Special
Emphasis Panel.
Time and Date: 12 p.m.-4 p.m., June 5, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of research grant applications received
in response to RFA DP07-002, ``Health Promotion and Disease
Prevention Research Centers: Special Interest Project Competitive
Supplements (Panel 7).''
Contact Person for More Information: Sheree Marshall Williams,
PhD, M.Sc., Scientific Review Administrator, Centers for Disease
Control and Prevention, 1600 Clifton Road, NE., MS D72, Atlanta, GA
30333, telephone 404.639.4896.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 10, 2007.
Elaine L. Baker
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-7332 Filed 4-17-07; 8:45 am]
BILLING CODE 4163-18-P
